Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

NCT01065454

TerminatedPhase 2

Sponsor: Bayer

Conditions: Hypertension, Pulmonary, Ventricular Dysfunction, Left

Interventions: Riociguat (Adempas, BAY63-2521), Riociguat (Adempas, BAY63-2521), Riociguat (Adempas, BAY63-2521), Placebo

Countries: United States, Australia, Austria, Belgium, Canada, China, Czechia, Denmark

The aim of this study is to assess whether increasing oral doses of Riociguat are safe and improve the well-being, symptoms and outcome in patients with pulmonary hypertension associated with left ventricular systolic dysfunction

Eligibility overview

Sex: ALL

Age: 18 Years to 80 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Male and female patients with symptomatic pulmonary hypertension due to left ventricular systolic dysfunction despite optimized heart failure therapy

Exclusion Criteria:

* Types of pulmonary hypertension other than group 2.1 of Dana Point Classification
Locations (83)
  • Los Angeles, California, United States
  • San Diego, California, United States
  • Torrance, California, United States
  • Westminster, California, United States
  • Miami, Florida, United States
  • Iowa City, Iowa, United States
  • Baltimore, Maryland, United States
  • Boston, Massachusetts, United States
  • Rochester, Minnesota, United States
  • St Louis, Missouri, United States
  • Cincinnati, Ohio, United States
  • Fairfield, Ohio, United States
  • Falls Church, Virginia, United States
  • Milwaukee, Wisconsin, United States
  • Sydney, New South Wales, Australia
  • Herston, Queensland, Australia
  • Melbourne, Victoria, Australia
  • Vienna, State of Vienna, Austria
  • Innsbruck, Tyrol, Austria
  • Aalst, Belgium
  • Brussels, Belgium
  • Ghent, Belgium
  • Leuven, Belgium
  • Edmonton, Alberta, Canada
  • Vancouver, British Columbia, Canada
  • Montreal, Quebec, Canada
  • Québec, Quebec, Canada
  • Beijing, China
  • Shanghai, China
  • Shanghai, China
  • + 53 more on CT.gov